Comparable Frequency of BRCA1, BRCA2 and TP53 Germline Mutations in a Multi-Ethnic Asian Cohort Suggests TP53 Screening Should Be Offered Together With BRCA1/2 Screening to Early-Onset Breast Cancer Patients

Breast Cancer Research - United Kingdom

doi 10.1186/bcr3165